# Current Platform Status

## Current Level

- Current patch level: Patch 82B after implementation.
- Patch 82B scope: frontend-only interactive dashboard and UI polish for Production Readiness Center and Production Operator Console. It adds local focus cards, filters, search, and drilldown-style details using already loaded data. No Supabase migration was applied, staging rehearsal remains pending, and production caveat remains unchanged.
- Patch 82 scope: staging migration rehearsal evidence for migrations 118 through 121. It is staging-only, does not apply production migrations, does not approve production launch, and requires blocker review before production deployment planning.
- Patch 81 scope: controlled Supabase migration and deployment runbook for migrations 118 through 121. It covers preflight, backup, staging-first validation, production apply planning, post-apply verification, rollback/containment, and evidence capture. Applying migrations does not equal production launch, and controlled production authority plus real hospital execution remain separate.
- Patch 80A scope: safe performance and smoothness optimization for heavy production readiness and operator pages. It adds memoized derived summaries, reduces repeated render-time scans, updates release proof coverage, and does not change schema, RLS, security behavior, governance logic, or production readiness decisions.
- Patch 79 scope: production operations governance, hypercare command center, 30/60/90 operating view, executive monthly governance reporting, accreditation/evidence pack tracking, and board closure pack readiness. Board closure does not approve production launch, controlled production authority remains separate, live transition requires separate operational execution, and real hospital execution evidence is still required.
- Patch 78 scope: identity, role, and data integrity hardening in Production Readiness. It adds access integrity review records, privileged role recertification evidence, dormant/inactive account review visibility, archived user access review, role duplication review, missing owner/reviewer repair tracking, department/station accountability, SSO/MFA readiness checklist status, and access export for IT/security review. Access integrity review does not approve production launch, and controlled production authority remains separate.
- Patch 77 scope: live pilot execution and issue burn-down in Production Readiness. It adds controlled live pilot sessions, pilot issue capture, retest evidence state, department pilot acceptance, pilot exit criteria, and issue burn-down visibility. Pilot readiness does not approve production launch, and controlled production authority remains separate.
- Patch 76 scope: controlled production authority and cutover gate in Production Readiness. It records executive authority decisions, critical blocker counts, limitation review state, cutover checklist completion, evidence gate snapshot, rationale, and decision audit history. This decision record does not automatically launch the system. Live transition requires separate operational execution.
- Patch 75 scope: clinical UX and navigation simplification. It keeps production operator and evidence closure surfaces available without exposing them as normal clinical navigation clutter.
- Patch 74 scope: final security and access review readiness in Production Evidence Closure. It summarizes security review state, access review state, privileged access review, dormant/inactive account review, archived user access review, RLS/bridge/security review evidence, department/station access accountability, and required actions before final security review. Security/access review does not approve production launch.
- Patch 73 scope: live support and incident readiness in Production Evidence Closure. It summarizes support desk readiness, escalation ownership, known issue register review, downtime/manual fallback readiness, incident intake and follow-up readiness, accepted limitations, and required actions before support readiness review. Support readiness does not approve production launch.
- Patch 72 scope: UAT pack and hospital pilot acceptance readiness in Production Evidence Closure. It summarizes UAT blockers, user testing evidence, pilot issue register signals, department pilot acceptance, accepted limitations requiring review, and required actions before pilot acceptance. UAT/pilot acceptance does not approve production launch.
- Patch 71 scope: live data quality and role integrity readiness in Production Evidence Closure. It summarizes data blockers, missing owner/reviewer assignments, inactive or archived owner/reviewer references where visible, department accountability gaps, evidence requiring more evidence, reopened evidence, and required actions before UAT. Data quality readiness does not approve production launch.
- Patch 70 scope: department launch final readiness workflow in Production Evidence Closure. It summarizes department/scope readiness, blockers, missing evidence, controlled closure actions, training/adoption/support, policy/SOP attestation, backup/restore/DR, access/security, and required actions before executive decision. Department readiness does not approve production launch; production launch and live transition remain future work requiring separate executive authority.
- Patch 69 scope: executive go/no-go decision pack readiness in Production Evidence Closure. It summarizes blockers, accepted limitations, controlled evidence action history, evidence-level closure status, and required actions before executive decision review without authorizing production launch.
- Patch 69 evidence note: Current patch level: Patch 69 represented executive go/no-go decision pack readiness before Patch 70 extended the same workflow with department launch final readiness.
- Evidence-level closure does not approve production launch. Production launch and live transition remain future work and require separate executive authority.
- Patch 68 scope: controlled evidence closure actions in Production Evidence Closure. It records evidence-level notes, ready-for-review, requests for more evidence, accepted limitations, verified closure, and reopen reasons through an audited bridge without approving production launch.
- Patch 67 scope: training, adoption, and support evidence readiness in Production Evidence Closure. It shows training/adoption/support readiness, missing adoption evidence summary, owner/reviewer readiness, due-date or overdue state, source workflow destination, and executive impact without adding direct write actions.
- Patch 66 scope: access review and security evidence readiness in Production Evidence Closure. It shows access/security evidence readiness, missing security evidence summary, owner/reviewer readiness, due-date or overdue state, source workflow destination, and executive impact without adding direct write actions.
- Patch 65 scope: backup, restore, and DR evidence readiness in Production Evidence Closure. It shows recovery evidence readiness, missing backup/restore/DR evidence summary, owner/reviewer readiness, due-date or overdue state, source workflow destination, and executive impact without adding direct write actions.
- Patch 64 scope: policy/SOP attestation evidence readiness in Production Evidence Closure. It shows attestation readiness, missing attestation evidence summary, owner/reviewer readiness, due-date or overdue state, source workflow destination, and executive impact without adding direct write actions.
- Patch 63 scope: department evidence coverage readiness in Production Evidence Closure. It shows department coverage state, missing evidence categories, owner/reviewer readiness, due-date and overdue summary, blocker/escalation summary, priority state, and next source workflow destination without adding direct write actions.
- Patch 62 scope: executive closure recommendation readiness in Production Evidence Closure. It shows a read-only executive recommendation state, reason, blocker/evidence/review counts, required executive actions, and source-workflow caveat without claiming production readiness.
- Patch 61 scope: evidence ownership and due-date readiness in Production Evidence Closure. It shows owner, reviewer, due date, overdue, blocked, escalation-readiness, and next-accountable-party signals without adding direct write actions.
- Patch 60 scope: reviewer decision readiness in Production Evidence Closure. It shows review readiness, required reviewer action, blocker reason, evidence needed before review, limitation decision need, and source workflow destination without adding direct write actions.
- Patch 59 scope: evidence action routing and closure handoff guidance only. It clarifies safe management destinations and next actions without adding direct closure writes.
- Patch 58 capability: Production Evidence Capture & Closure Workflow for live hospital evidence gaps, owner follow-up, review state, limitations, recovery assurance, and executive closure readiness.
- Patch 58.1 scope: validation/runtime command structure only. It reduces duplicate nested validation work and adds fast, build, proof, security, release, and profiling lanes.
- Patch 58.2 scope: repository hygiene and release noise restore coverage only. It archives legacy root patch helper files and extends generated proof JSON cleanup coverage.
- Patch 57 capability: Production Operator Console for the daily operating view across production readiness, hospital rollout, hypercare, access, recovery, adoption, policy/SOP, and executive action.
- Patch 56 scope: release, proof, and script consolidation only. It adds no platform workflow capability, database migration, RLS change, or runtime behavior change.
- Patch 55 remains the latest hospital operations readiness capability: department launch packs, support readiness, policy/SOP attestation, and adoption readiness.
- Current validation baseline: typecheck, build, Patch 55 chain, full proof suite, and runtime security.

## Before Pull Request

Run:

```powershell
npm run validate:release
npm run release:restore-noise
```

## After Merge

Run on `main` after pulling:

```powershell
npm run validate:release
npm run release:restore-noise
git status --short --branch
```

## Production Caveat

Real hospital-wide production still requires live department launch evidence, user training adoption, policy/SOP attestations, support readiness, backup and restore evidence, DR restore evidence, live pilot issue burn-down, retest evidence, department pilot acceptance, identity/access integrity review, privileged role recertification, production operations governance, hypercare evidence, board closure review, staging migration rehearsal evidence, controlled migration deployment evidence, and executive signoff. Controlled production authority records, board closure, staging rehearsal evidence, migration deployment evidence, access integrity review, pilot readiness, security/access review, support readiness, UAT/pilot acceptance, data quality readiness, and department readiness do not automatically launch the system, and live transition requires separate operational execution.

`proof:all` and `v700:runtime-security` remain required gates. After validation, run `npm run release:restore-noise` to remove expected generated release artifact churn unless intentionally updating release evidence.

Use `npm run validate:fast` for the local development loop, `npm run validate:build` for build readiness, `npm run validate:proof` for the proof suite, `npm run validate:security` for runtime security, and `npm run validate:release` for the full release gate.

## Evidence Locations

- Technical validation artifacts: `release/v700/`, `release/v64/`, `release/v66/`, `release/v672/`, `release/v673/`, and `release/v674/`.
- Patch release evidence: `release/patch43/` through `release/patch82b/`.
- Current production readiness, pilot/hypercare, hospital operations evidence, and closure follow-up are surfaced in the Production Readiness Center, Production Operator Console, and Production Evidence Closure page.
- Current proof command index: `release/current-proof-command-index.md`.
- Current validation runbook: `release/current-validation-runbook.md`.
